Inspira Technologies Oxy B.H.N. Ltd. IINN

Full chart Compare
Set alert

Price alert · IINN

All alert types
1.05 USD 0.00 (+0.00%)

Aug 7, 2026, 9:30 AM EDT

0.9801 Day range 1.06
0.761 52-week range 2.49
YTD
+16.67%
1 year
+32.91%
Market cap
21.46M
EPS (ttm)
-0.78
Shares out
18.50M
Forward P/E
-1.66
YTD return
+16.67%
1-year return
+32.91%
Volume
1.53M
Avg volume
152.02K
Open
1.04
Previous close
1.05
Day's range
0.9801 – 1.06
52-week range
0.761 – 2.49
Beta
2.09
Earnings date
Jul 1, 2024

 

No chart data for this range yet.

Key statistics

Enterprise value
7.71M
PEG ratio
0.00
Price / sales
0.00
Price / book
3.16
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
0.00%
Free cash flow
-4.74M
Total cash
7.36M
Total debt
878.00K
Return on equity
-116.54%
Short % of float
1.13%
50-day average
1.29
200-day average
1.50

Next earnings

Jul 1, 2024

Expected Jul 1, 2024. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
IINN Revenue — quarterly 0
2020-Q3 20202020-Q4 20202021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q4 20222023-Q1 20232023-Q2 2023
IINN Net income — quarterly -9.21M
2020-Q3 20202020-Q4 20202021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q4 20222023-Q1 20232023-Q2 2023

Earnings

IINN recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Jul 1, 2024Mar 1, 20240.00———
Mar 29, 2024Dec 1, 20230.00———

About Inspira Technologies Oxy B.H.N. Ltd.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of proprietary life support technology for the treatment of acute respiratory failure. Its lead product is the INSPIRA augmented respiration technology (Gen 2) device, a life support designed to provide Adaptive Blood Oxygenation that to elevate and stabilize declining oxygen saturation levels. The company has a strategic collaboration with Westchester Medical Center to advance critical patient care with the deployment of Inspira's proprietary INSPIRA ART100 systems. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.

Sector
Healthcare
Industry
Medical Devices
Country
Israel

News

Your note

Sign in to keep a note on IINN — it syncs with the Stock Master app.

Institution ownership

IINN institution ownership
Holder% heldSharesValueReported
IEQ Capital, LLC0.30%51,94960.26KSep 29, 2024
Citadel Advisors Llc0.10%16,60419.26KSep 29, 2024
Renaissance Technologies, LLC0.09%15,09017.50KSep 29, 2024
Avantax Advisory Services, Inc.0.09%15,00017.40KSep 29, 2024
Xtx Topco Ltd0.09%14,92117.31KSep 29, 2024
Laidlaw Wealth Management LLC0.08%13,50015.66KSep 29, 2024

Fund ownership

IINN fund ownership
Holder% heldSharesValueReported
Fidelity NASDAQ Composite Index Fund0.02%2,9243.39KOct 30, 2024